论文信息 - Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. - 字舞流文

Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial.

S. Roychowdhury | A. Lamarca | I. Borbath | D. Oh | T. Macarulla | L. Goyal | S. Makawita | M. Javle | Ai Li | A. Cohn | S. Sadeghi | A. Pande | M. Howland | T. Cho | Ghassan K Abou-Alfa | Rachna T Shroff